MEGAN FARMER: Open Payments
NPI 1689159261 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,607 in 74 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $1,405 · 2025 $1,607
Food & beverage: $1,607
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $463 |
| E.R. Squibb & Sons, L.L.C. | 10 | $181 |
| PFIZER INC. | 7 | $152 |
| Kestra Medical Technology Services, Inc. | 6 | $142 |
| AstraZeneca Pharmaceuticals LP | 6 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $63 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $53 |
| Medtronic, Inc. | 2 | $50 |
| Amgen Inc. | 3 | $46 |
| Novo Nordisk Inc | 2 | $40 |
Products named: LEQVIO, ELIQUIS, Assure WCD, CAMZYOS, WAINUA, JARDIANCE, LifeVest, REPATHA.
Industry payments across GA — which companies pay providers there.
